Julie Desrivot Selected Research

GLPG1205

1/2021

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Desrivot Research Topics

Disease

4	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Atrioventricular Block 01/2018
1	Cholangiocarcinoma 01/2018
1	Infections 01/2018
1	Crohn Disease (Crohn's Disease) 01/2016
1	Rheumatoid Arthritis 01/2016

Drug/Important Bio-Agent (IBA)

3	GLPG1690IBA 10/2019 - 01/2018
1	GLPG1205IBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	lysophosphatidic acidIBA 01/2019
1	GLPG0634IBA 01/2016
1	Janus Kinase 1IBA 01/2016